secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001367644-25-000087
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions authorizes $50M share repurchase program through March 2026
--------------------------------------------------------------------------------

- Board authorized repurchase of up to $50 million of common stock on or before March 27, 2026.
- CEO Joe Papa cites confidence in strategy, future outlook and cash generation as rationale.
- Company had approximately 54.3 million shares outstanding as of December 31, 2024.
- Repurchases may be made on open market or in private transactions; timing subject to market conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764425000087/0001367644-25-000087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764425000087/ebs-20250331.htm
  HTML page:      https://secwatch.observer/filing/0001367644-25-000087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer